Literature DB >> 21996313

Type I interferon response to extracellular bacteria in the airway epithelium.

Dane Parker1, Alice Prince.   

Abstract

The airway epithelium possesses many mechanisms to prevent bacterial infection. Not only does it provide a physical barrier, but it also acts as an extension of the immune system through the expression of innate immune receptors and corresponding effectors. One outcome of innate signaling by the epithelium is the production of type I interferons (IFNs), which have traditionally been associated with activation via viral and intracellular organisms. We discuss how three extracellular bacterial pathogens of the airway activate this intracellular signaling cascade through both surface components as well as via secretion systems, and the differing effects of type I IFN signaling on host defense of the respiratory tract.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21996313      PMCID: PMC3221817          DOI: 10.1016/j.it.2011.09.003

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  89 in total

1.  A Toll-like receptor recognizes bacterial DNA.

Authors:  H Hemmi; O Takeuchi; T Kawai; T Kaisho; S Sato; H Sanjo; M Matsumoto; K Hoshino; H Wagner; K Takeda; S Akira
Journal:  Nature       Date:  2000-12-07       Impact factor: 49.962

2.  The cytosolic nucleic acid sensor LRRFIP1 mediates the production of type I interferon via a beta-catenin-dependent pathway.

Authors:  Pengyuan Yang; Huazhang An; Xingguang Liu; Mingyue Wen; Yuanyuan Zheng; Yaocheng Rui; Xuetao Cao
Journal:  Nat Immunol       Date:  2010-05-09       Impact factor: 25.606

3.  Staphylococcus aureus protein A induces airway epithelial inflammatory responses by activating TNFR1.

Authors:  Marisa I Gómez; Aram Lee; Bharat Reddy; Amanda Muir; Grace Soong; Allyson Pitt; Ambrose Cheung; Alice Prince
Journal:  Nat Med       Date:  2004-07-11       Impact factor: 53.440

4.  Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays.

Authors:  S D Der; A Zhou; B R Williams; R H Silverman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

Review 5.  Innate immunity in the respiratory epithelium.

Authors:  Dane Parker; Alice Prince
Journal:  Am J Respir Cell Mol Biol       Date:  2011-02-17       Impact factor: 6.914

6.  Role of autolysin in generating the pneumococcal purpura-producing principle.

Authors:  C Chetty; A Kreger
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

7.  Participation of CD11c(+) leukocytes in methicillin-resistant Staphylococcus aureus clearance from the lung.

Authors:  Francis J Martin; Dane Parker; Bryan S Harfenist; Grace Soong; Alice Prince
Journal:  Infect Immun       Date:  2011-03-14       Impact factor: 3.441

8.  TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta.

Authors:  Jonathan C Kagan; Tian Su; Tiffany Horng; Amy Chow; Shizuo Akira; Ruslan Medzhitov
Journal:  Nat Immunol       Date:  2008-02-24       Impact factor: 25.606

9.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.

Authors:  A Poltorak; X He; I Smirnova; M Y Liu; C Van Huffel; X Du; D Birdwell; E Alejos; M Silva; C Galanos; M Freudenberg; P Ricciardi-Castagnoli; B Layton; B Beutler
Journal:  Science       Date:  1998-12-11       Impact factor: 47.728

10.  CXCR3 ligands contribute to Th1-induced inflammation but not to homing of Th1 cells into the lung.

Authors:  Anne M Manicone; Kristi M Burkhart; Bao Lu; Joan G Clark
Journal:  Exp Lung Res       Date:  2008-09       Impact factor: 2.459

View more
  28 in total

Review 1.  Innate Immune Signaling Activated by MDR Bacteria in the Airway.

Authors:  Dane Parker; Danielle Ahn; Taylor Cohen; Alice Prince
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

2.  Beneficial innate signaling interference for antibacterial responses by a Toll-like receptor-mediated enhancement of the MKP-IRF3 axis.

Authors:  Hideo Negishi; Kosuke Matsuki; Nobuyasu Endo; Hana Sarashina; Shoji Miki; Atsushi Matsuda; Keiko Fukazawa; Naoko Taguchi-Atarashi; Hiroaki Ikushima; Hideyuki Yanai; Junko Nishio; Kenya Honda; Yoichiro Fujioka; Yusuke Ohba; Tetsuo Noda; Shun'ichiro Taniguchi; Eisuke Nishida; Yongliang Zhang; Hongbo Chi; Richard A Flavell; Tadatsugu Taniguchi
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-18       Impact factor: 11.205

3.  MyD88- and TRIF-independent induction of type I interferon drives naive B cell accumulation but not loss of lymph node architecture in Lyme disease.

Authors:  Christine J Hastey; Jennine Ochoa; Kimberley J Olsen; Stephen W Barthold; Nicole Baumgarth
Journal:  Infect Immun       Date:  2014-01-22       Impact factor: 3.441

4.  Impact of Type I and III Interferons on Respiratory Superinfections Due to Multidrug-Resistant Pathogens.

Authors:  Dane Parker
Journal:  J Infect Dis       Date:  2017-02-15       Impact factor: 5.226

Review 5.  Critical role of type I interferon-induced macrophage necroptosis during infection with Salmonella enterica serovar Typhimurium.

Authors:  Shujuan Liang; Xuebin Qin
Journal:  Cell Mol Immunol       Date:  2012-12-24       Impact factor: 11.530

6.  Toll-like receptor expression and induction of type I and type III interferons in primary airway epithelial cells.

Authors:  Ioannis Ioannidis; Fang Ye; Beth McNally; Meredith Willette; Emilio Flaño
Journal:  J Virol       Date:  2013-01-09       Impact factor: 5.103

7.  Plasmacytoid dendritic cell-derived IFNα modulates Th17 differentiation during early Bordetella pertussis infection in mice.

Authors:  V Wu; A A Smith; H You; T A Nguyen; R Ferguson; M Taylor; J E Park; P Llontop; K R Youngman; T Abramson
Journal:  Mucosal Immunol       Date:  2015-10-14       Impact factor: 7.313

8.  Staphylococcus aureus induces type I IFN signaling in dendritic cells via TLR9.

Authors:  Dane Parker; Alice Prince
Journal:  J Immunol       Date:  2012-09-07       Impact factor: 5.422

9.  Oral delivery of oligomeric procyanidins in Apple Poly® enhances type I IFN responses in vivo.

Authors:  Deann T Snyder; Amanda Robison; Sharon Kemoli; Emily Kimmel; Jeff Holderness; Mark A Jutila; Jodi F Hedges
Journal:  J Leukoc Biol       Date:  2014-01-13       Impact factor: 4.962

10.  Type I Interferon Counters or Promotes Coxiella burnetii Replication Dependent on Tissue.

Authors:  Jodi F Hedges; Amanda Robison; Emily Kimmel; Kelly Christensen; Erin Lucas; Andrew Ramstead; Mark A Jutila
Journal:  Infect Immun       Date:  2016-05-24       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.